Onconetix, Inc. Operating Leases, Rent Expense
Onconetix, Inc. (ONCO) reported Operating Leases, Rent Expense of $48.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2023-05-12
- Onconetix, Inc. operating leases, rent expense for the quarter ending 2023-03-31 was $48.00K.
- Onconetix, Inc. operating leases, rent expense for the quarter ending 2022-09-30 was $53.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month |
|---|---|---|---|
| 2023-03-31 | $48.00K 10-Q · filed 2023-05-12 | ||
| 2022-09-30 | $53.00K 10-Q · filed 2022-11-14 | $89.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $36.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |